Cubist Systematic Strategies, LLC Avanos Medical, Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$17.64 - $22.99 $480,143 - $625,764	27,219 New	27,219 $610,000
Q2 2023 Aug 14, 2023	SELL	$22.53 - $30.98 $654,293 - $899,690	-29,041 Reduced 99.91%	25 $0
Q1 2023 May 15, 2023	SELL	$26.92 - $31.75 $28,346 - $33,432	-1,053 Reduced 3.5%	29,066 $864,000
Q4 2022 Feb 14, 2023	SELL	$19.88 - $27.37 $700,869 - $964,929	-35,255 Reduced 53.93%	30,119 $815,000
Q3 2022 Nov 14, 2022	SELL	$21.56 - $29.59 $414,900 - $569,429	-19,244 Reduced 22.74%	65,374 $1.42 Million
Q2 2022 Aug 15, 2022	SELL	$24.87 - $34.68 $1.94 Million - $2.71 Million	-78,074 Reduced 47.99%	84,618 $2.31 Million
Q1 2022 May 16, 2022	BUY	$28.87 - $35.77 $2.75 Million - $3.41 Million	95,239 Added 141.19%	162,692 $5.45 Million
Q4 2021 Feb 14, 2022	SELL	$29.25 - $36.02 $369,778 - $455,364	-12,642 Reduced 15.78%	67,453 $2.34 Million
Q3 2021 Nov 15, 2021	BUY	$31.2 - $38.5 $1.92 Million - $2.37 Million	61,512 Added 331.01%	80,095 $2.5 Million
Q2 2021 Aug 16, 2021	BUY	$36.37 - $45.72 $161,228 - $202,676	4,433 Added 31.33%	18,583 $676,000
Q1 2021 May 17, 2021	SELL	$43.5 - $53.4 $1.04 Million - $1.28 Million	-23,910 Reduced 62.82%	14,150 $619,000
Q4 2020 Feb 16, 2021	SELL	$33.15 - $49.5 $102,466 - $153,004	-3,091 Reduced 7.51%	38,060 $1.75 Million
Q3 2020 Nov 16, 2020	SELL	$28.67 - $34.32 $14,793 - $17,709	-516 Reduced 1.24%	41,151 $1.37 Million
Q2 2020 Aug 14, 2020	BUY	$23.48 - $33.86 $416,159 - $600,134	17,724 Added 74.03%	41,667 $1.23 Million
Q1 2020 May 15, 2020	SELL	$20.64 - $34.41 $355,358 - $592,436	-17,217 Reduced 41.83%	23,943 $645,000
Q4 2019 Feb 14, 2020	BUY	$31.89 - $47.34 $1.08 Million - $1.61 Million	34,010 Added 475.66%	41,160 $1.39 Million
Q3 2019 Nov 14, 2019	BUY	$32.06 - $44.0 $229,229 - $314,600	7,150 New	7,150 $268,000
Q1 2019 May 15, 2019	SELL	$39.84 - $51.04 $43,824 - $56,144	-1,100 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$41.16 - $66.67 $222,099 - $359,751	-5,396 Reduced 83.07%	1,100 $49,000
Q3 2018 Nov 14, 2018	BUY	$55.13 - $72.65 $358,124 - $471,934	6,496 New	6,496 $445,000

Others Institutions Holding AVNS

# of Institutions

273

Shares Held

42.9M

Call Options Held

5.4K

Put Options Held

Black Rock Inc. New York, NY

7.01M
Shares

$121 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

5.32M
Shares

$91.6 Million
0.0% of portfolio
Rgm Capital, LLC Naples, FL

3.17M
Shares

$54.6 Million
3.28% of portfolio
Dimensional Fund Advisors LP Austin, TX

2.59M
Shares

$44.6 Million
0.02% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

2.37M
Shares

$40.8 Million
0.03% of portfolio

View Full List

About AVANOS MEDICAL, INC.

Ticker AVNS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 46,487,000
Market Cap $801M
Description
Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...

More about AVNS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account